PHARMACYTE BIOTECH INC (PMCB)       2.75  -0.08 (-2.83%)

2.75  -0.08 (-2.83%)

US71715X2036 - Common Stock - After market: 2.85 +0.1 (+3.64%)

2022
(2022-4-30)
2021
(2021-4-30)
2020
(2020-4-30)
2019
(2019-4-30)
2018
(2018-4-30)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
-4.24M-3.55M-3.83M-4.07M-6.83M
Depreciation Amortization
N/AN/AN/AN/AN/A
Interest Paid
510.002.27K450.00N/AN/A
Taxes Paid
1.60K800.00800.00N/AN/A
OPERATING CASH FLOW
-4.12M-3.33M-2.34M-2.88M-5.08M
 
CASH FLOWS FROM INVESTING ACTIVITIES
Other Investing Activity
0.000.000.000.000.00
INVESTING CASH FLOW
0.000.000.000.000.00
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
-50.81K-62.44K62.85KN/AN/A
Stock Issued/Repurchased
87.36M4.70M2.66M2.34M2.68M
Other Financing Activity
N/AN/A-10.00KN/AN/A
FINANCING CASH FLOW
87.31M4.64M2.73M2.34M2.68M
 
Exchange Rate Effect
4.63K1.33K-7.87K-9.13K-6.45K
CHANGE IN CASH
83.20M1.31M379.61K-544.54K-2.40M
 
CHANGE IN WORKING CAPITAL
9.04K-145.61K267.35K167.10K-85.87K
 
FREE CASH FLOW
Operating Cash Flow
-4.12M-3.33M-2.34M-2.88M-5.08M

All data in USD

Charts